Post Approval Study of the Eversense® Continuous Glucose Monitoring
Public ClinicalTrials.gov record NCT03908125. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
Study identification
- NCT ID
- NCT03908125
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Senseonics, Inc.
- Industry
- Enrollment
- 273 participants
Conditions and interventions
Interventions
- Eversense® CGM System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 18, 2019
- Primary completion
- Jan 31, 2024
- Completion
- Jan 31, 2024
- Last update posted
- Jun 11, 2025
2019 – 2024
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hoag Memorial Hospital Presbyterian/Mary Dick Allen Diabetes Center | Newport Beach | California | 92663 | — |
| Denver Endocrinology, Diabetes & Thyroid Center | Englewood | Colorado | 80113 | — |
| The Center for Diabetes and Endocrine Care | Fort Lauderdale | Florida | 33312 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| MODEL Clinical research | Baltimore | Maryland | 21204 | — |
| Metro Detroit Endocrinology Center | Dearborn | Michigan | 48126 | — |
| Diabetes and Endocrinology Specialists, Inc. | Chesterfield | Missouri | 63017 | — |
| Albany Medical College | Albany | New York | 12206 | — |
| Physicians East | Greenville | North Carolina | 27834 | — |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Diabetes & Endocrinology Consultants of Pennsylvania, LLC | Feasterville | Pennsylvania | 19053 | — |
| AM Diabetes & Endocrinology | Bartlett | Tennessee | 38133 | — |
| Texas Diabetes and Endocrinology | Austin | Texas | 78731 | — |
| Clinical Research Solution, LLC | Cypress | Texas | 77433 | — |
| Javara, Inc | Houston | Texas | 77095 | — |
| Diabetes and Glandular Disease Clinic | San Antonio | Texas | 78229 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03908125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03908125 live on ClinicalTrials.gov.